Alaa Elwan

New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studies

Hazem Elkady, Alaa Elwan, Hesham A. El‐Mahdy et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 122 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents

Souad A. El‐Metwally, Mohsen M. Abou-El-Regal, Ibrahim H. Eissa et al. · Bioorganic Chemistry · 2021 · 117 citations

Pharmacy, Medicinal Chemistry, Oncology +13

Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers

Mohammed M. Alanazi, Ibrahim H. Eissa, Nawaf A. Alsaif et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 92 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors

Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr et al. · Bioorganic Chemistry · 2020 · 78 citations

Pharmacy, Chemistry, Medicinal Chemistry +17

Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-<i>a</i>:3',4'-<i>c</i>]quinoxaline derivatives as anticancer agents and apoptosis inducers

Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15